Found 16 de-dermatology trials
A listing of de-dermatology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
The purpose of this study is to identify the clinical and biological characteristics of HS. Subject over the age of 18 diagnosed with HS will have one initial study visit and then be seen every 6 months during their standard routine clinic visit. First visit will consist of completing a …
This study is being done to help researchers understand if specific genetic mutations are associated with atopic dermatitis or eczema are present in patients who identify as Latino(a) or Hispanic.
This is a retrospective chart review study assessing real-world treatment patterns and outcomes in patients with cutaneous T-cell lymphoma (CTCL) treated with extracorporeal photopheresis (ECP), interferons, and/or bexarotene. De-identified data will be abstracted from existing medical records to evaluate demographics, treatment sequences, and clinical responses in adult patients with MF …
This Phase 2b, multicenter, randomized, double-blind, placebo-controlled study evaluates the safety and efficacy of ORKA-001, a biologic targeting IL-23, in adults with moderate-to-severe plaque psoriasis. Participants will undergo screening labs, questionnaires, physical exams, and receive subcutaneous study drug or placebo with regular safety and efficacy assessments.
The purpose of this research is to learn more about the use of an investigational medicine, called brepocitinib, for the treatment of lichen planopilaris (LPP) in adults. Procedures include medication administration, medical history, vitals, EKG, chest x-ray, photography, biopsy (if needed for diagnosis), blood and urine collection, physician and participant …
This study is for adults with moderate-to-severe plaque psoriasis who have already participated in a previous Oruka Therapeutics study and choose to continue receiving ORKA-001 treatment. Participants may stay in the extension study for up to about 96 weeks and will then be followed for about 48 weeks after their …
This is a multi-site, interventional trial which evaluates the efficacy of delgocitinib cream for treating mild to severe lichen sclerosus (LS) in adults. The trial is conducted in 2 parts. Part 1 of the trial enrolls female participants with LS and results in the selection of the optimal dose for …
The project will estimate the prevalence of RV-associated cutaneous granulomas in normal adult population over a 15-year period and assess the frequency and intensity of virus shedding by these long-term RV carriers. These results will help ascertain the impact of long-term RV carriers that could influence the maintenance of rubella …
Our goal is to identify markers which can predict response to therapy in patients with dermatomyositis, systemic sclerosis, lupus erythematosus, morphea, eosinophilic fasciitis, and other immune-mediated cutaneous and rheumatic diseases. To collect human tissue from lesional and non-lesional skin, as well as blood, cheek swabs, photographs of biopsy site(s) or …
The purpose of this research is to measure clinical safety and efficacy of oral brepocitinib in adults 18 and over diagnosed with cutaneous sarcoidosis. Procedures include Medical history, Physical exam, EKG, PFT, Photography, Biopsy, blood and urine collection.
1 - 10 of 16
- 1
- 2
Please choose between Voice or SMS based delivery of verification code
or